LFCR logo

Lifecore Biomedical (LFCR) EBITDA

Annual EBITDA

$36.46 M
+$69.63 M+209.93%

May 26, 2024

Summary

Performance

1-Year Change

+209.93%

3-Year Change

+3794.33%

5-Year Change

+51.3%

15-Year Change

+36.68%

LFCR EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

84.63%
LFCR annual EBITDA is higher than 84.63% of companies in Healthcare sector

High & Low

All-time High

$41.57 M
LFCR annual EBITDA is currently -12.28% below its historical high of $41.57 million

3-Year Low

-$33.17 M

Earnings dates

Last Annual Earnings Report Date

May 26, 2024
LFCR previous annual earnings announcement was published on May 26, 2024

Next Annual Earnings Report Date

N/A
LFCR next annual earnings announcement has not yet been scheduled

OtherLFCRprofitabilitymetrics:

Annual Revenue

$128.26 M
LFCR annual revenue is $128.26 million

Annual Net Income

$12.01 M
LFCR annual net profit is $12.01 million

Annual EBIT

$27.60 M
LFCR annual earnings before interest & taxes is $27.60 million

Annual EPS

$0.32
LFCR annual earnings per share is $0.32

Quarterly EBITDA

$981.00 K
+$9.88 M+111.03%

November 24, 2024

Summary

Performance

3-Month Change

+111.03%

1-Year Change

-95.53%

3-Year Change

-95.53%

5-Year Change

+181.14%

LFCR Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

76.19%
LFCR quarterly EBITDA is higher than 76.19% of companies in Healthcare sector

High & Low

All-time High

$27.05 M
LFCR quarterly EBITDA is currently -96.37% below its historical high of $27.05 million

3-Year Low

-$28.19 M

Earnings dates

Last Quarterly Earnings Report Date

Nov 24, 2024
LFCR previous earnings announcement was published on Nov 24, 2024

Next Quarterly Earnings Report Date

Apr 8, 2025
LFCR next earnings announcement is scheduled for Apr 8, 2025

OtherLFCRprofitabilitymetrics:

Quarterly Revenue

$32.56 M
LFCR quarterly revenue is $32.56 million

Quarterly Net Income

-$6.57 M
LFCR quarterly net profit is -$6.57 million

Quarterly EBIT

-$1.06 M
LFCR quarterly earnings before interest & taxes is -$1.06 million

Quarterly EPS

-$0.25
LFCR quarterly earnings per share is -$0.25

TTM EBITDA

$14.95 M
-$19.04 M-56.01%

November 24, 2024

Summary

Performance

3-Month Change

-56.01%

1-Year Change

+102.71%

3-Year Change

+102.71%

5-Year Change

+601.85%

LFCR TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

80.42%
LFCR TTM EBITDA is higher than 80.42% of companies in Healthcare sector

High & Low

All-time High

$41.70 M
LFCR TTM EBITDA is currently -64.15% below its historical high of $41.70 million

3-Year Low

-$40.47 M

Earnings dates

Last Quarterly Earnings Report Date

Nov 24, 2024
LFCR previous earnings announcement was published on Nov 24, 2024

Next Quarterly Earnings Report Date

Apr 8, 2025
LFCR next earnings announcement is scheduled for Apr 8, 2025

OtherLFCRprofitabilitymetrics:

TTM Revenue

$130.86 M
LFCR TTM revenue is $130.86 million

TTM Net Income

-$14.25 M
LFCR TTM net profit is -$14.25 million

TTM EBIT

$5.99 M
LFCR TTM earnings before interest & taxes is $5.99 million

TTM EPS

-$0.59
LFCR TTM earnings per share is -$0.59

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$36.46 M
LFCR annual EBITDA is $36.46 million

Annual Net Income

$12.01 M
LFCR annual net profit is $12.01 million

Annual Interest Expense

$18.09 M
LFCR annual interest expense is $18.09 million

Annual Income Tax

$183.00 K
LFCR annual income tax is $183.00 thousand

Annual D&A

$8.86 M
LFCR annual depreciation & amortization is $8.86 million

LFCR EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+209.9%-95.5%+102.7%
3 y3 years+3794.3%-95.5%+102.7%
5 y5 years+51.3%+181.1%+601.9%

LFCR EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+209.9%-95.5%+103.5%-59.0%+136.9%
5 y5-yearat high+209.9%-95.5%+103.5%-59.0%+136.9%
alltimeall time-12.3%+209.9%-96.4%+103.2%-64.2%+136.9%

Lifecore Biomedical EBITDA History

DateAnnualQuarterlyTTM
Nov 2024
-
$981.00 K(-111.0%)
$14.95 M(-56.0%)
Aug 2024
-
-$8.89 M(-1089.3%)
$33.98 M(-6.8%)
May 2024
$36.46 M(-209.9%)
$899.00 K(-95.9%)
$36.46 M(+394.4%)
Feb 2024
-
$21.96 M(+9.7%)
$7.38 M(-141.4%)
Nov 2023
-
$20.02 M(-412.0%)
-$17.80 M(-56.0%)
Aug 2023
-
-$6.42 M(-77.2%)
-$40.47 M(+22.0%)
May 2023
-$33.17 M(-358.3%)
-$28.19 M(+777.1%)
-$33.17 M(+840.2%)
Feb 2023
-
-$3.21 M(+21.3%)
-$3.53 M(-692.9%)
Nov 2022
-
-$2.65 M(-400.3%)
$595.00 K(-95.6%)
Aug 2022
-
$882.00 K(-39.3%)
$13.39 M(-10.5%)
May 2022
$12.84 M(-1401.3%)
$1.45 M(+59.8%)
$14.95 M(+1543.2%)
Feb 2022
-
$909.00 K(-91.0%)
$910.00 K(-85.8%)
Nov 2021
-
$10.14 M(+314.3%)
$6.40 M(-153.4%)
Aug 2021
-
$2.45 M(-119.4%)
-$11.98 M(-44.3%)
May 2021
-$987.00 K(-86.2%)
-
-
May 2021
-
-$12.59 M(-296.8%)
-$21.53 M(+293.4%)
Feb 2021
-
$6.40 M(-177.7%)
-$5.47 M(-74.8%)
Nov 2020
-
-$8.24 M(+16.1%)
-$21.72 M(+47.9%)
Aug 2020
-
-$7.10 M(-304.8%)
-$14.69 M(+105.1%)
May 2020
-$7.16 M(-129.7%)
$3.47 M(-135.2%)
-$7.16 M(+140.4%)
Feb 2020
-
-$9.85 M(+714.5%)
-$2.98 M(-120.4%)
Nov 2019
-
-$1.21 M(-381.8%)
$14.61 M(-27.6%)
Aug 2019
-
$429.00 K(-94.4%)
$20.18 M(-16.3%)
May 2019
$24.10 M(-21.7%)
$7.65 M(-1.2%)
$24.10 M(-17.0%)
Feb 2019
-
$7.74 M(+77.1%)
$29.02 M(+2.1%)
Nov 2018
-
$4.37 M(+0.5%)
$28.41 M(+1.2%)
Aug 2018
-
$4.35 M(-65.4%)
$28.08 M(-8.7%)
May 2018
$30.76 M(+15.3%)
$12.57 M(+76.4%)
$30.76 M(+32.3%)
Feb 2018
-
$7.13 M(+76.5%)
$23.26 M(-4.3%)
Nov 2017
-
$4.04 M(-42.5%)
$24.30 M(-3.8%)
Aug 2017
-
$7.02 M(+38.6%)
$25.27 M(-5.3%)
May 2017
$26.68 M(-421.0%)
$5.07 M(-37.9%)
$26.68 M(-15.0%)
Feb 2017
-
$8.17 M(+63.1%)
$31.39 M(-501.2%)
Nov 2016
-
$5.01 M(-40.7%)
-$7.82 M(+7.7%)
Aug 2016
-
$8.44 M(-13.7%)
-$7.27 M(-12.6%)
May 2016
-$8.31 M(-127.4%)
$9.78 M(-131.5%)
-$8.31 M(-8.9%)
Feb 2016
-
-$31.05 M(-658.0%)
-$9.13 M(-130.0%)
Nov 2015
-
$5.56 M(-24.7%)
$30.39 M(-5.5%)
Aug 2015
-
$7.39 M(-17.5%)
$32.16 M(+5.8%)
May 2015
$30.39 M(-21.5%)
$8.96 M(+5.8%)
$30.39 M(-1.1%)
Feb 2015
-
$8.47 M(+15.5%)
$30.74 M(-10.5%)
Nov 2014
-
$7.33 M(+30.5%)
$34.34 M(-1.2%)
Aug 2014
-
$5.62 M(-39.6%)
$34.75 M(-10.2%)
May 2014
$38.69 M(-6.9%)
$9.31 M(-22.8%)
$38.69 M(+3.4%)
Feb 2014
-
$12.07 M(+55.8%)
$37.42 M(+6.2%)
Nov 2013
-
$7.75 M(-18.9%)
$35.26 M(-15.5%)
Aug 2013
-
$9.56 M(+18.8%)
$41.70 M(+0.3%)
May 2013
$41.57 M(+54.9%)
$8.05 M(-18.7%)
$41.57 M(+5.3%)
Feb 2013
-
$9.90 M(-30.3%)
$39.47 M(+1.6%)
Nov 2012
-
$14.20 M(+50.6%)
$38.84 M(+22.6%)
Aug 2012
-
$9.43 M(+58.5%)
$31.66 M(+18.0%)
May 2012
$26.83 M(+84.1%)
$5.95 M(-35.8%)
$26.83 M(+33.5%)
Feb 2012
-
$9.27 M(+32.0%)
$20.10 M(+25.6%)
Nov 2011
-
$7.02 M(+52.9%)
$16.01 M(+15.3%)
Aug 2011
-
$4.59 M(-685.2%)
$13.88 M(-4.8%)
May 2011
$14.57 M(+19.7%)
-$785.00 K(-115.2%)
$14.58 M(-9.2%)
Feb 2011
-
$5.18 M(+5.7%)
$16.06 M(+9.9%)
Nov 2010
-
$4.90 M(-7.4%)
$14.62 M(+11.9%)
Aug 2010
-
$5.29 M(+658.7%)
$13.06 M(+7.2%)
DateAnnualQuarterlyTTM
May 2010
$12.18 M(-28.5%)
$697.00 K(-81.3%)
$12.18 M(-22.7%)
Feb 2010
-
$3.73 M(+11.9%)
$15.75 M(+1.2%)
Nov 2009
-
$3.34 M(-24.3%)
$15.57 M(+1.8%)
Aug 2009
-
$4.41 M(+3.3%)
$15.29 M(-5.8%)
May 2009
$17.04 M(-7.3%)
$4.27 M(+20.4%)
$16.23 M(+16.1%)
Feb 2009
-
$3.55 M(+15.9%)
$13.98 M(-16.4%)
Nov 2008
-
$3.06 M(-42.9%)
$16.73 M(-8.3%)
Aug 2008
-
$5.36 M(+165.0%)
$18.25 M(+6.0%)
May 2008
$18.38 M(-45.3%)
$2.02 M(-67.9%)
$17.22 M(-13.8%)
Feb 2008
-
$6.29 M(+37.4%)
$19.99 M(-50.9%)
Nov 2007
-
$4.58 M(+6.0%)
$40.75 M(+9.6%)
Aug 2007
-
$4.32 M(-9.7%)
$37.19 M(+10.6%)
May 2007
$33.63 M(+175.0%)
$4.79 M(-82.3%)
$33.62 M(-7.7%)
Feb 2007
-
$27.05 M(+2534.3%)
$36.44 M(+165.7%)
Nov 2006
-
$1.03 M(+35.8%)
$13.71 M(+9.1%)
Aug 2006
-
$756.00 K(-90.1%)
$12.57 M(+2.8%)
May 2006
$12.23 M(+28.9%)
$7.61 M(+75.8%)
$12.22 M(+22.0%)
Feb 2006
-
$4.33 M(-3646.7%)
$10.02 M(+9.5%)
Nov 2005
-
-$122.00 K(-129.4%)
$9.15 M(-3.7%)
Aug 2005
-
$415.00 K(-92.3%)
$9.50 M(+0.1%)
May 2005
$9.48 M(+22.2%)
$5.40 M(+56.3%)
$9.48 M(-2.5%)
Feb 2005
-
$3.46 M(+1428.8%)
$9.73 M(+19.4%)
Nov 2004
-
$226.00 K(-43.9%)
$8.15 M(+7.2%)
Aug 2004
-
$403.00 K(-92.9%)
$7.60 M(-2.1%)
May 2004
$7.76 M(+78.5%)
$5.65 M(+201.6%)
$7.76 M(-1.8%)
Feb 2004
-
$1.87 M(-683.2%)
$7.90 M(+56.9%)
Nov 2003
-
-$321.00 K(-156.9%)
$5.04 M(-6.3%)
Aug 2003
-
$564.00 K(-90.3%)
$5.37 M(+5.1%)
May 2003
$4.35 M(-8.6%)
-
-
Apr 2003
-
$5.79 M(-683.3%)
$5.12 M(-14.1%)
Jan 2003
-
-$992.00 K(-6300.0%)
$5.95 M(+25.1%)
Oct 2002
$4.76 M(+71.0%)
$16.00 K(-94.8%)
$4.76 M(+12.9%)
Jul 2002
-
$305.00 K(-95.4%)
$4.21 M(+8.0%)
Apr 2002
-
$6.62 M(-402.9%)
$3.90 M(+42.1%)
Jan 2002
-
-$2.19 M(+313.4%)
$2.74 M(-0.9%)
Oct 2001
$2.78 M(-35.1%)
-$529.00 K(+6512.5%)
$2.77 M(+6.8%)
Jul 2001
-
-$8000.00(-100.1%)
$2.59 M(-36.7%)
Apr 2001
-
$5.47 M(-352.8%)
$4.10 M(+21.5%)
Jan 2001
-
-$2.16 M(+206.8%)
$3.37 M(-20.4%)
Oct 2000
$4.29 M(-287.3%)
-$705.00 K(-147.1%)
$4.24 M(+165.6%)
Jul 2000
-
$1.50 M(-68.4%)
$1.59 M(-222.5%)
Apr 2000
-
$4.74 M(-464.9%)
-$1.30 M(-38.6%)
Jan 2000
-
-$1.30 M(-61.1%)
-$2.12 M(+5.0%)
Oct 1999
-$2.29 M(+90.8%)
-$3.35 M(+139.0%)
-$2.02 M(+161.0%)
Jul 1999
-
-$1.40 M(-135.7%)
-$774.00 K(+107.0%)
Apr 1999
-
$3.93 M(-427.2%)
-$374.00 K(-68.8%)
Jan 1999
-
-$1.20 M(-42.9%)
-$1.20 M(0.0%)
Oct 1998
-$1.20 M(-84.8%)
-$2.10 M(+110.0%)
-$1.20 M(-340.0%)
Jul 1998
-
-$1.00 M(-132.3%)
$500.00 K(0.0%)
Apr 1998
-
$3.10 M(-358.3%)
$500.00 K(-107.4%)
Jan 1998
-
-$1.20 M(+200.0%)
-$6.80 M(-8.1%)
Oct 1997
-$7.90 M(+107.9%)
-$400.00 K(-60.0%)
-$7.40 M(-2.6%)
Jul 1997
-
-$1.00 M(-76.2%)
-$7.60 M(-3.8%)
Apr 1997
-
-$4.20 M(+133.3%)
-$7.90 M(+79.5%)
Jan 1997
-
-$1.80 M(+200.0%)
-$4.40 M(+100.0%)
Oct 1996
-$3.80 M
-$600.00 K(-53.8%)
-$2.20 M(+37.5%)
Jul 1996
-
-$1.30 M(+85.7%)
-$1.60 M(+433.3%)
Apr 1996
-
-$700.00 K(-275.0%)
-$300.00 K(-175.0%)
Jan 1996
-
$400.00 K
$400.00 K

FAQ

  • What is Lifecore Biomedical annual EBITDA?
  • What is the all time high annual EBITDA for Lifecore Biomedical?
  • What is Lifecore Biomedical annual EBITDA year-on-year change?
  • What is Lifecore Biomedical quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Lifecore Biomedical?
  • What is Lifecore Biomedical quarterly EBITDA year-on-year change?
  • What is Lifecore Biomedical TTM EBITDA?
  • What is the all time high TTM EBITDA for Lifecore Biomedical?
  • What is Lifecore Biomedical TTM EBITDA year-on-year change?

What is Lifecore Biomedical annual EBITDA?

The current annual EBITDA of LFCR is $36.46 M

What is the all time high annual EBITDA for Lifecore Biomedical?

Lifecore Biomedical all-time high annual EBITDA is $41.57 M

What is Lifecore Biomedical annual EBITDA year-on-year change?

Over the past year, LFCR annual EBITDA has changed by +$69.63 M (+209.93%)

What is Lifecore Biomedical quarterly EBITDA?

The current quarterly EBITDA of LFCR is $981.00 K

What is the all time high quarterly EBITDA for Lifecore Biomedical?

Lifecore Biomedical all-time high quarterly EBITDA is $27.05 M

What is Lifecore Biomedical quarterly EBITDA year-on-year change?

Over the past year, LFCR quarterly EBITDA has changed by -$20.98 M (-95.53%)

What is Lifecore Biomedical TTM EBITDA?

The current TTM EBITDA of LFCR is $14.95 M

What is the all time high TTM EBITDA for Lifecore Biomedical?

Lifecore Biomedical all-time high TTM EBITDA is $41.70 M

What is Lifecore Biomedical TTM EBITDA year-on-year change?

Over the past year, LFCR TTM EBITDA has changed by +$7.58 M (+102.71%)